313 related articles for article (PubMed ID: 32513170)
1. Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis.
Wang J; Li P; Wen J
BMC Health Serv Res; 2020 Jun; 20(1):519. PubMed ID: 32513170
[TBL] [Abstract][Full Text] [Related]
2. Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis.
Guo X; Xiao Y; Liu H; Li Q; Jiang Q; Liu C; Xie F; Wang H; Yang F; Han X; Yang H; Yang Y; Ye Y; Gan X; Long E
Front Public Health; 2023; 11():1079655. PubMed ID: 37188279
[TBL] [Abstract][Full Text] [Related]
3. Impacts of government supervision on hospitalization costs for inpatients with COPD: An interrupted time series study.
Li P; Duan Z; Zhang Z; He Y; Li W; Jin Wen
Medicine (Baltimore); 2020 Jan; 99(5):e18977. PubMed ID: 32000429
[TBL] [Abstract][Full Text] [Related]
4. The impact of zero markup drug policy on patients' healthcare utilization and expense: An interrupted time series study.
Zhu Z; Wang J; Sun Y; Zhang J; Han P; Yang L
Front Med (Lausanne); 2022; 9():928690. PubMed ID: 36457568
[TBL] [Abstract][Full Text] [Related]
5. Impact of the zero-mark-up drug policy on drug-related expenditures and use in public hospitals, 2016-2018: an interrupted time series study in Shaanxi.
Yan K; Yang C; Zhang H; Ye D; Liu S; Chang J; Jiang M; Zhao M; Fang Y
BMJ Open; 2020 Nov; 10(11):e037034. PubMed ID: 33243788
[TBL] [Abstract][Full Text] [Related]
6. Impacts of the Zero-Markup Drug Policy on Hospitalization Expenses of Patients with Stroke in Western China: An Interrupted Time Series Analysis.
Wu Y; Han X; Qiu J
Risk Manag Healthc Policy; 2024; 17():777-788. PubMed ID: 38584876
[TBL] [Abstract][Full Text] [Related]
7. Impact of China's zero mark-up drug policy on drug cost of NCDs' outpatients: an interrupted time series analysis.
Du J; Xie J; Qian Y; Wu M; Huang W; Yin J; Peng X; Deng D
BMC Health Serv Res; 2021 Apr; 21(1):404. PubMed ID: 33926444
[TBL] [Abstract][Full Text] [Related]
8. Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level-A hospital in China: A single centre, interrupted time series.
Lan T; Guan L; Pang X; Li X; Yu Q
J Clin Pharm Ther; 2022 Jan; 47(1):104-111. PubMed ID: 34668203
[TBL] [Abstract][Full Text] [Related]
9. The Effect of the Full Coverage of Essential Medicines Policy on Utilization and Accessibility of Primary Healthcare Service for Rural Seniors: A Time Series Study in Qidong, China.
Wang Y; Zhu Y; Shi H; Sun X; Chen N; Li X
Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31698773
[No Abstract] [Full Text] [Related]
10. Effects of different mark-up drug policies on drug-related expenditures in tertiary public hospitals: an interrupted time series study in Shanghai, China, 2015-2018.
Wang X; Li F; Wang X; Zhang X; Liu C; Wang D; Wang H; Chen Y
Biosci Trends; 2020 Mar; 14(1):16-22. PubMed ID: 32092747
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effectiveness of comprehensive drug price reform: a case study from Shihezi city in Western China.
Lin T; Wu Z; Liu M; Wu X; Zhang X
Int J Equity Health; 2020 Aug; 19(1):133. PubMed ID: 32762691
[TBL] [Abstract][Full Text] [Related]
12. Will the zero-margin drug policy reduce the economic burden of stroke patients in China?
Fang Q; Shang D; Zhang Y; Geng X; Liu F; Zhang Q; Wang X
J Glob Health; 2021; 11():08007. PubMed ID: 34671464
[TBL] [Abstract][Full Text] [Related]
13. The influence of the national drug price negotiation policy reform on the medical expenses of patients in Xuzhou City: an interrupted time series analysis.
Qin Z; He M; Shen H; Liu S; Xu S; Chen L
Front Public Health; 2024; 12():1381786. PubMed ID: 38903594
[TBL] [Abstract][Full Text] [Related]
14. "The biggest reform to China's health system": did the zero-markup drug policy achieve its goal at traditional Chinese medicines county hospitals?
Shi X; Zhu D; Man X; Wang W; Zhu K; Nicholas S; He P
Health Policy Plan; 2019 Sep; 34(7):483-491. PubMed ID: 31363744
[TBL] [Abstract][Full Text] [Related]
15. The impact of "4 + 7" volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis.
Yang Y; Tong R; Yin S; Mao L; Xu L; Hao S; Mao Z
BMC Health Serv Res; 2021 Nov; 21(1):1275. PubMed ID: 34823516
[TBL] [Abstract][Full Text] [Related]
16. Effects of Chinese medical pricing reform on the structure of hospital revenue and healthcare expenditure in county hospital: an interrupted time series analysis.
Liu M; Jia M; Lin Q; Zhu J; Wang D
BMC Health Serv Res; 2021 Apr; 21(1):385. PubMed ID: 33902578
[TBL] [Abstract][Full Text] [Related]
17. Trends in Hospitalization Expenditures for Acute Exacerbations of COPD in Beijing from 2009 to 2017.
Liang L; Shang Y; Xie W; Shi J; Tong Z; Jalali MS
Int J Chron Obstruct Pulmon Dis; 2020; 15():1165-1175. PubMed ID: 32547004
[TBL] [Abstract][Full Text] [Related]
18. The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis.
Wang R; Li X; Gu X; Cai Q; Wang Y; Yi ZM; Chen LC
Front Public Health; 2023; 11():1159119. PubMed ID: 37228740
[TBL] [Abstract][Full Text] [Related]
19. Impacts of unifying urban and rural residents' medical insurance on the hospitalisation expenses of rural patients in eastern China: an interrupted time series analysis.
Qin Z; Liu S; Zhou M; Chen L; Huang W; Shen L
BMJ Open; 2023 May; 13(5):e067198. PubMed ID: 37230522
[TBL] [Abstract][Full Text] [Related]
20. Different impacts of the zero-markup drug policy on county general and traditional Chinese medicine hospitals: evidence from Shandong province, China.
Jiang X; He P; Zhu D; Shi X; Meng Q
Int J Equity Health; 2020 Dec; 19(1):219. PubMed ID: 33302978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
